A generalmethod to access diverse chiral phenols by rhodium-catalyzed asymmetric conjugate arylation using hydroxylated arylboronic acids in ethanol was developed. Recycling of the rhodium catalyst by flash chromatography on silica gel was feasible in this system. The synthetic utility of the strategy was demonstrated by efficient synthesis of chiral drug tolterodine.
[EN] LEUKOTRIENE SYNTHESIS INHIBITORS<br/>[FR] INHIBITEURS DE LA SYNTHÈSE DES LEUCOTRIÈNES
申请人:NAEGIS PHARMACEUTICALS INC
公开号:WO2020146822A1
公开(公告)日:2020-07-16
Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.